FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dominique Costagliola

Research Profile

Disorders

Living Beings

HIV-1

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

France

Physiology

Co-author Network

Publications

TOP 3
Jacques D A Ndawinz; Barnabe Okouda; Severin Tchomthe; Ambroise Abanda; Basile Chaix; Dominique Costagliola; Eric Delaporte; Sinata Koulla-Shiro; Etienne Mboui; Virginie Supervie
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Asier Sáez-Cirión; Alain Venet; Pierre Versmisse; Jean-Paul Viard; Brigitte Autran; Véronique Avettand-Fenoel; Charline Bacchus; Faroudy Boufassa; Dominique Costagliola; Benjamin Descours; Isabelle Girault; Cécile Goujard; Julien Guergnon; Laurent Hocqueloux; Olivier Lambotte; Camille Lecuroux; Adeline Melard; Laurence Meyer; Gianfranco Pancino; Valerie Potard; Thierry Prazuck; Christine Rouzioux
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
Christophe Piketty; Ali Si-Mohamed; Selma Trabelsi; Roland Tubiana; Laurence Weiss; Béatrice Cochand-Priollet; Dominique Costagliola; Pierre-Marie Girard; Emilie Lanoy
Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dominique Costagliola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jacques D A Ndawinz; Barnabe Okouda; Severin Tchomthe; Ambroise Abanda; Basile Chaix; Dominique Costagliola; Eric Delaporte; Sinata Koulla-Shiro; Etienne Mboui; Virginie Supervie
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
The Journal of antimicrobial chemotherapy 2013;68(6):1388-99.
2013: Asier Sáez-Cirión; Alain Venet; Pierre Versmisse; Jean-Paul Viard; Brigitte Autran; Véronique Avettand-Fenoel; Charline Bacchus; Faroudy Boufassa; Dominique Costagliola; Benjamin Descours; Isabelle Girault; Cécile Goujard; Julien Guergnon; Laurent Hocqueloux; Olivier Lambotte; Camille Lecuroux; Adeline Melard; Laurence Meyer; Gianfranco Pancino; Valerie Potard; Thierry Prazuck; Christine Rouzioux
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
PLoS pathogens 2013;9(3):e1003211.
2013: Christophe Piketty; Ali Si-Mohamed; Selma Trabelsi; Roland Tubiana; Laurence Weiss; Béatrice Cochand-Priollet; Dominique Costagliola; Pierre-Marie Girard; Emilie Lanoy
Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.
AIDS (London, England) 2013;27(3):401-6.
2012: Christophe Piketty; Hana Selinger-Leneman; Murielle Mary-Krause; Laurent Abramowitz; Aurelien Belot; Manuela Bonmarchand; Anne-Marie Bouvier; Dominique Costagliola; Claudine Duvivier; Sophie Grabar
Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4360-6.
2012: Jean-Philippe Spano; Dominique Costagliola; Christine Katlama; Emilie Lanoy; Nicolas Mounier; Isabelle Heard
Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications.
European journal of cancer (Oxford, England : 1990) 2012;48(18):3335-41.
2012: Virginie Supervie; Dominique Costagliola
Undiagnosed HIV prevalence in France: no evidence against universal HIV screening.
AIDS (London, England) 2012;26(18):2419; author reply 2419-21.
2012: Randa Bittar; Dominique Bonnefont-Rousselot; Corinne Cherfils; Dominique Costagliola; MC Federspiel; Philippe Giral; Olga Kalmykova; Marc-Antoine Valantin; Elisabeth Aslangul; Lambert Assoumou
Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.
AIDS (London, England) 2012;26(14):1801-5.
2012: Sylvie Rozenberg; Marc-Antoine Valantin; Jean-Paul Viard; Michelle Bentata; Dominique Costagliola; Iuliana Darasteanu; Sami Kolta; Emilie Lanoy; Pascale Missy; Christian Roux
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
AIDS research and human retroviruses 2012;28(9):972-80.
2012: Jean-Marie Goehrs; Thomas Borel; Dominique Costagliola
[In Process Citation].
Thérapie 2012;67(4):375-80.
2012: Randa Bittar; Dominique Bonnefont-Rousselot; Dominique Costagliola; Valérie Fesel-Fouquier; Philippe Giral; Olga Kalmykova; Marc-Antoine Valantin; Elisabeth Aslangul; Lambert Assoumou
Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients.
Antiviral therapy 2012;17(5):855-60.
2011: Jacques D A Ndawinz; Dominique Costagliola; Virginie Supervie
New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France.
AIDS (London, England) 2011;25(15):1905-13.
2011: Victor Appay; Brigitte Autran; Dominique Costagliola; Steven G Deeks; Solène Fastenackels; Beatrix Grubeck-Loebenstein; Amélie Guihot; Peter W Hunt; Christine Katlama; Michael Keller; Olivier Lambotte; Luminita Schneider; Anne Simon; Hocine Ait Mohand; Delphine Sauce
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.
AIDS (London, England) 2011;25(15):1813-22.
2011: T Bommenel; Dominique Costagliola; J Gilquin; C Katlama; Anne-Sophie Lascaux; O Launay; Aba Mahamat; V Martinez; J L Meynard; C Pradier; E Rouveix; A Simon; Sophie Abgrall
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.
The Journal of antimicrobial chemotherapy 2011;66(8):1869-77.
2011: Delphine Sauce; Martin Larsen; Solène Fastenackels; Michèle Pauchard; Hocine Ait Mohand; Luminita Schneider; Amélie Guihot; Faroudy Boufassa; John Zaunders; Malika Iguertsira; Michelle Bailey; Guy Gorochov; Claudine Duvivier; Guislaine Carcelain; Anthony D Kelleher; Anne Simon; Laurence Meyer; Dominique Costagliola; Steven G Deeks; Olivier Lambotte; Brigitte Autran; Peter W Hunt; Christine Katlama; Victor Appay
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
Blood 2011;117(19):5142-51.
2011: Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
Annals of internal medicine 2011;154(8):509-15.
2011: David Brieger; Jean-Philippe Collet; Johanne SILVAIN; Antoine Landivier; Olivier Barthélémy; Farzin Beygui; Anne Bellemain-Appaix; Anne Mercadier; Rémi Choussat; Nicolas Vignolles; Dominique Costagliola; Gilles Montalescot
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;77(2):182-90.
2011: François Boué; Jacques Reynes; Christine Rouzioux; Dominique Emilie; Faouzi Souala; Rolland Tubiana; Cécile Goujard; Rémi Lancar; Dominique Costagliola
Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial.
AIDS (London, England) 2011;25(1):115-8.
2011: Jacques Gasnault; Houria Hendel-Chavez; Rémi Lancar; Anne-Sophie Lascaux; Anne-Aurélie Mazet; Sophie Pakianather; Lydie Porte; Yassine Taoufik; Dominique Costagliola; Marie-Ghislaine de Goer de Herve; Jean-François Delfraissy; Anne Dulioust
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
PloS one 2011;6(6):e20967.
2010: Christophe Piketty; Laurence Weiss; Lambert Assoumou; Marianne Burgard; Aurélie Mélard; Jean-Michel Ragnaud; Michele Bentata; Pierre-Marie Girard; Christine Rouzioux; Dominique Costagliola
A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
Journal of medical virology 2010;82(11):1819-28.
2010: Jing Xie; Wei Lu; Assia Samri; Dominique Costagliola; Aurélie Schnuriger; Bosco C M da Silva; C Blanc; Martin Larsen; Ioannis Theodorou; Christine Rouzioux; Brigitte Autran
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control.
AIDS (London, England) 2010;24(15):2323-9.
2010: Emilie Lanoy; Dominique Costagliola; Eric A Engels
Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.
International journal of cancer. Journal international du cancer 2010;126(7):1724-31.
2010: Marc-Antoine Valantin; R Bittar; pierre de truchis; D Bollens; L Slama; P Giral; D Bonnefont-Rousselot; P Pétour; C Aubron-Olivier; Dominique Costagliola; Christine Katlama
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.
The Journal of antimicrobial chemotherapy 2010;65(3):556-61.
2010: Amélie Guihot; Roland Tubiana; Guillaume Breton; Anne-Geneviève Marcelin; Assia Samri; Lambert Assoumou; Emilia Goncalves; François Bricaire; Dominique Costagliola; Vincent Calvez; Christine Rouzioux; Brigitte Autran; Christine Katlama; Guislaine Carcelain
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
AIDS (London, England) 2010;24(4):614-7.
2010: Almoustapha Issiaka Maïga; Diane Descamps; Laurence Morand-Joubert; Isabelle Malet; Anne Derache; Mamadou Cisse; Victoria Koita; Alain Akonde; Bah Diarra; Marc Wirden; Anatole Tounkara; Yvan Verlinden; Christine Katlama; Dominique Costagliola; Bernard Masquelier; Vincent Calvez; Anne-Geneviève Marcelin
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes.
Antimicrobial agents and chemotherapy 2010;54(2):728-33.
2010: Mojgan Hessamfar-Bonarek; Philippe Morlat; Dominique Salmon; Patrice Cacoub; thierry may; Fabrice Bonnet; Eric Rosenthal; Dominique Costagliola; Charlotte Lewden; Geneviève Chêne
Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).
International journal of epidemiology 2010;39(1):135-46.
2010: Lauren E Cain; Dominique Costagliola; Emilie Lanoy; Roger Logan; James M Robins; Miguel A Hernán
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.
The international journal of biostatistics 2010;6(2):Article 18.
2010: Xavier Colin; Antoine Lafuma; Dominique Costagliola; Erik Smets; Josephine Mauskopf; Pascal Guillon
Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.
PharmacoEconomics 2010;28 Suppl 1():183-97.
2010: Xavier Colin; Antoine Lafuma; Dominique Costagliola; Jean-Marie Lang; Pascal Guillon
The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France.
PharmacoEconomics 2010;28 Suppl 1():59-68.
2009: Emilie Lanoy; Margaret May; Amanda Mocroft; Andrew Phillip; Amy Justice; Geneviève Chêne; Hansjakob Furrer; Timothy Sterling; Antonella d'Arminio Monforte; Lluís Force; John Gill; Ross Harris; Hogg Robert; Jürgen Rockstroh; Mike Saag; Pavel Khaykin; Frank de Wolf; Jonathan A C Sterne; Dominique Costagliola
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
AIDS (London, England) 2009;23(16):2199-208.
2009: Christian Mouala; Marguerite Guiguet; Sandrine Houzé; Florence Damond; Gilles Pialoux; Nathalie Viget; Dominique Costagliola; Jacques Le Bras; sophie matheron
Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
AIDS (London, England) 2009;23(15):1997-2004.
2009: Benoît Marin; Rodolphe Thiébaut; Heiner C Bucher; Virginie Rondeau; Dominique Costagliola; Maria Dorrucci; Osamah Hamouda; Maria Prins; Sarah Walker; Kholoud Porter; Caroline Sabin; Geneviève Chêne
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
AIDS (London, England) 2009;23(13):1743-53.
2009: Cathia Soulié; Lambert Assoumou; Jade Ghosn; Claudine Duvivier; Gilles Peytavin; Zaina Ait-Arkoub; Jean-Michel Molina; Dominique Costagliola; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
AIDS (London, England) 2009;23(12):1605-8.
2009: Sophie Grabar; Hana Selinger-Leneman; Sophie Abgrall; Gilles Pialoux; Laurence Weiss; Dominique Costagliola
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.
AIDS (London, England) 2009;23(9):1163-9.
2009: Eric Rosenthal; D Salmon-Céron; Charlotte Lewden; V Bouteloup; G Pialoux; Fabrice Bonnet; M Karmochkine; thierry may; M François; Christine Burty; Eric Jougla; Dominique Costagliola; Philippe Morlat; Geneviève Chêne; Patrice Cacoub
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).
HIV medicine 2009;10(5):282-9.
2009: Dominique Salmon-Ceron; Eric Rosenthal; Charlotte Lewden; Vincent Bouteloup; thierry may; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Patrice Cacoub; Geneviève Chêne
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
Journal of hepatology 2009;50(4):736-45.
2009: Fabrice Bonnet; Christine Burty; Charlotte Lewden; Dominique Costagliola; thierry may; Vincent Bouteloup; Eric Rosenthal; Eric Jougla; Patrice Cacoub; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):633-9.
2009: Miguel A Hernán; Mara McAdams; Nuala McGrath; Emilie Lanoy; Dominique Costagliola
Observation plans in longitudinal studies with time-varying treatments.
Statistical methods in medical research 2009;18(1):27-52.
2009: Marguerite Guiguet; Eric Kendjo; Guislaine Carcelain; Sophie Abgrall; Murielle Mary-Krause; Pierre Tattevin; Yazdan Yazdanpanah; Dominique Costagliola; Xavier Duval
CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.
Antiviral therapy 2009;14(3):451-7.
2008: Hervé Foulot; Isabelle Heard; Valérie Potard; Dominique Costagliola; Charles Chapron
Surgical management of cervical intraepithelial neoplasia in HIV-infected women.
European journal of obstetrics, gynecology, and reproductive biology 2008;141(2):153-7.
2008: Jean-Philippe Spano; Dominique Costagliola; Christine Katlama; Nicolas Mounier; Eric Oksenhendler; David Khayat
AIDS-related malignancies: state of the art and therapeutic challenges.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4834-42.
2008: Claudine Duvivier; Jade Ghosn; Lambert Assoumou; Cathia Soulié; Gilles Peytavin; Vincent Calvez; Michèle Algarté Génin; Jean-Michel Molina; Olivier Bouchaud; Christine Katlama; Dominique Costagliola
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
The Journal of antimicrobial chemotherapy 2008;62(4):797-808.
2008: Marc-Antoine Valantin; Emilie Lanoy; Michelle Bentata; O Kalmykova; A Boutekadjirt; Clotilde Allavena; Willy Rozenbaum; Gilles Peytavin; Bahia Amellal; Vincent Calvez; Dominique Costagliola; Christine Katlama
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
HIV medicine 2008;9(8):625-35.
2008: Christian Mouala; Sandrine Houzé; Marguerite Guiguet; Philippe Abboud; Gilles Pialoux; Nathalie Viget; Dominique Costagliola; sophie matheron
Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study.
Journal of acquired immune deficiency syndromes (1999) 2008;49(1):55-60.
2008: Charlotte Lewden; thierry may; Eric Rosenthal; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Dominique Salmon; Patrice Cacoub; Geneviève Chêne
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):590-8.
2008: Lambert Assoumou; Françoise Brun-Vézinet; Alessandro Cozzi-Lepri; Daniel Kuritzkes; Andrew Phillips; Andrew Zolopa; Victor DeGruttola; Veronica Miller; Dominique Costagliola
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
The Journal of infectious diseases 2008;198(4):470-80.
2008: Brigitte Autran; Robert L Murphy; Dominique Costagliola; Roland Tubiana; Bonaventura Clotet; Jose Gatell; Schlomo Staszewski; Norma Wincker; Lambert Assoumou; Raphaelle El Habib; Vincent Calvez; Bruce Walker; Christine Katlama
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).
AIDS (London, England) 2008;22(11):1313-22.
2008: Christophe Piketty; Hana Selinger-Leneman; Sophie Grabar; Claudine Duvivier; Manuela Bonmarchand; Laurent Abramowitz; Dominique Costagliola; Murielle Mary-Krause
Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
AIDS (London, England) 2008;22(10):1203-11.
2008: Sophie Grabar; Emilie Lanoy; Clotilde Allavena; M Mary-Krause; Michelle Bentata; P Fischer; Aba Mahamat; C Rabaud; Dominique Costagliola
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
HIV medicine 2008;9(4):246-56.
2008: Annika Vogt; Brice Mahé; Dominique Costagliola; Olivia Bonduelle; Sabrina Hadam; Gregor Schaefer; Hans Schaefer; Christine Katlama; Wolfram Sterry; Brigitte Autran; Ulrike Blume-Peytavi; Behazine Combadiere
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(3):1482-9.
2008: Hana Selinger-Leneman; Sophie Matheron; Aba Mahamat; Jacques Moreau; Dominique Costagliola; Sophie Abgrall
Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):206-11.
2008: Isabelle Kousignian; Sophie Abgrall; Sophie Grabar; Aba Mahamat; Elina Teicher; Elisabeth Rouveix; Dominique Costagliola
Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(2):296-304.
2008: Marguerite Guiguet; Kholoud Porter; Andrew Phillips; Dominique Costagliola; Abdel Babiker
Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART).
The open AIDS journal 2008;2():3-9.
2008: Laurence Slama; Emilie Lanoy; Marc-Antoine Valantin; Jean-Philippe Bastard; Aziza Chermak; Amal Boutekatjirt; Demiana William-Faltaos; Eric Billaud; Jean-Michel Molina; Jacqueline Capeau; Dominique Costagliola; Willy Rozenbaum
Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).
Antiviral therapy 2008;13(1):67-76.
2007: F Lanternier; Cécile Dalban; L Perez; F Bricaire; Dominique Costagliola; E Caumes
Tolerability of anti-tuberculosis treatment and HIV serostatus.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2007;11(11):1203-9.
2007: Cathia Soulié; Anne-Geneviève Marcelin; Jade Ghosn; Bahia Amellal; Lambert Assoumou; Sidonie Lambert; Claudine Duvivier; Dominique Costagliola; Christine Katlama; Vincent Calvez
HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
AIDS (London, England) 2007;21(16):2243-5.
2007: Virginie Supervie; Dominique Costagliola
BSE risk assessment as a basis for updating French screening policy.
Risk analysis : an official publication of the Society for Risk Analysis 2007;27(5):1131-40.
2007: Jorge Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel C Douek; Brigitte Autran; Victor Appay
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.
The Journal of experimental medicine 2007;204(10):2473-85.
2007: Dominique Costagliola; Diane Descamps; Lambert Assoumou; Laurence Morand-Joubert; Anne-Geneviève Marcelin; Véronique Brodard; Constance Delaugerre; Vincent Mackiewicz; Annick Ruffault; Jacques Izopet; Jean-Christophe Plantier; Catherine Tamalet; Sabine Yerly; Souhaha Saidi; Françoise Brun Vezinet; Bernard Masquelier
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):12-8.
2007: Virginie Supervie; Dominique Costagliola
Estimating incidence of the French BSE infection using a joint analysis of both asymptomatic and clinical BSE surveillance data.
Mathematical biosciences 2007;209(1):90-107.
2007: Dominique Costagliola
[Can a large epidemic for the new variant of Creutzfeldt-Jakob disease be feared?].
Médecine sciences : M/S 2007;23(5):550.
2007: Isabelle Malet; Bénédicte Roquebert; Cécile Dalban; Marc Wirden; Bahia Amellal; Rachid Agher; Anne Simon; Christine Katlama; Dominique Costagliola; Vincent Calvez; Anne-Geneviève Marcelin
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
The Journal of infection 2007;54(4):367-74.
2007: Min Ji Kim; Pascale Leclercq; Emilie Lanoy; Pascale Cervera; Barbara Antuna-Puente; Mustapha Maachi; Elena Dorofeev; Laurence Slama; Mare Antoine Valantin; Dominique Costagliola; Anne Lombes; Jean-Philippe Bastard; Jacqueline Capeau
A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
Antiviral therapy 2007;12(8):1273-83.
2007: Emilie Lanoy; Murielle Mary-Krause; Pierre Tattevin; Isabelle Perbost; Isabelle Poizot-Martin; Caroline Dupont; Dominique Costagliola
Frequency, determinants and consequences of delayed access to care for HIV infection in France.
Antiviral therapy 2007;12(1):89-96.
2007: Sophie Abgrall; Patrick Yeni; Olivier Bouchaud; Dominique Costagliola
Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):120-7.
2006: Charlotte Lewden; Eric Jougla; A Alioum; Gérard Pavillon; L Lièvre; Philippe Morlat; Dominique Salmon; thierry may; Geneviève Chêne; Dominique Costagliola
Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation.
Epidemiology and infection 2006;134(6):1345-52.
2006: Laurence Lievre; Christiane Deveau; Juliette Gerbe; Patricia Enel; Laurent Tran; Nathalie De Castro; Dominique Costagliola; Laurence Meyer
Yearly number of patients diagnosed with primary HIV-1 infection in France estimated by a capture-recapture approach.
AIDS (London, England) 2006;20(18):2392-5.
2006: L Fardet; Murielle Mary-Krause; Isabelle Heard; M Partisani; Dominique Costagliola
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.
HIV medicine 2006;7(8):520-9.
2006: Sophie Abgrall; Patrick Yeni; Olivier Bouchaud; Dominique Costagliola
Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
AIDS (London, England) 2006;20(16):2099-106.
2006: Christian Roux; Karine Briot; Nathalie Dumarcet; Michel Bourgoin; Roland D Chapurlat; Sophie Christin-Maitre; Bernard Cortet; Dominique Costagliola; Vincent Diebolt; François Lacoin; Brigitte Letombe; Flavien Oberlin; Philippe Orcel; Philippe Ravaud; Patrick Seret; Thierry Thomas; Jean-Yves Vogel; Alexandre Barna; Emmanuel Nouyrigat; Marie-Laure Veyries; Isabelle Yoldjian
[Drug treatment of postmenopausal osteoporosis. What's New in 2006].
Presse médicale (Paris, France : 1983) 2006;35(10 Pt 2):1529-39.
2006: Vincent Vieillard; Dominique Costagliola; Anne Simon; Patrice Debré
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
AIDS (London, England) 2006;20(14):1795-804.
2006: François Boué; Jean Gabarre; Christian Gisselbrecht; Jacques Reynes; Antoine Cheret; Fabrice Bonnet; Eric Billaud; Martine Raphael; Remi Lancar; Dominique Costagliola
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4123-8.
2006: Murielle Mary-Krause; Eric Billaud; Isabelle Poizot-Martin; Anne Simon; Catherine Dhiver; Caroline Dupont; Dominique Salmon; Laurent Roudiere; Dominique Costagliola
Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
AIDS (London, England) 2006;20(12):1627-35.
2006: Emilie Lanoy; Murielle Mary-Krause; Pierre Tattevin; Rosemary Dray-Spira; Claudine Duvivier; Patricia Fischer; Yolande Obadia; France Lert; Dominique Costagliola
Predictors identified for losses to follow-up among HIV-seropositive patients.
Journal of clinical epidemiology 2006;59(8):829-835.
2006: Sophie Grabar; Bruno Abraham; Aba Mahamat; Pascal Del Giudice; Eric Rosenthal; Dominique Costagliola
Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3408-14.
2006: Miguel A Hernán; Emilie Lanoy; Dominique Costagliola; James M Robins
Comparison of dynamic treatment regimes via inverse probability weighting.
Basic & clinical pharmacology & toxicology 2006;98(3):237-42.
2006: Marina Vignot; Lucia Perez; Fanny Lanternier; Dominique Costagliola; Eric Caumes; François Bricaire
[Nursing surveillance during antitubercular drug treatment].
Soins; la revue de référence infirmière 2006;(703):19-21.
2006: Virginie Supervie; Dominique Costagliola
How was the French BSE epidemic underestimated?
Comptes rendus biologies 2006;329(2):106-16.
2006: Isabelle Heard; Valérie Potard; Dominique Costagliola
Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Antiviral therapy 2006;11(8):1091-6.
2006: Odile Launay; Xavier Duval; Cécile Dalban; Diane Descamps; Gilles Peytavin; Agnès Certain; Saïd Mouajjah; Pascal Ralaimazava; Renaud Verdon; Dominique Costagliola; François Clavel
Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
Antiviral therapy 2006;11(7):889-99.
2006: Sophie Grabar; Laurence Weiss; Dominique Costagliola
HIV infection in older patients in the HAART era.
The Journal of antimicrobial chemotherapy 2006;57(1):4-7.
2005: Constance Delaugerre; Gilles Peytavin; Stephanie Dominguez; Anne-Geneviève Marcelin; Claudine Duvivier; Karine Gourlain; Bahia Amellal; Mayeule Legrand; François Raffi; Dominique Costagliola; Christine Katlama; Vincent Calvez
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Journal of medical virology 2005;77(3):345-50.
2005: Jade Ghosn; Marc Wirden; Nadine Ktorza; Gilles Peytavin; Hocine Aït-Mohand; Luminita Schneider; Stephanie Dominguez; François Bricaire; Vincent Calvez; Dominique Costagliola; Christine Katlama
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.
AIDS (London, England) 2005;19(15):1643-7.
2005: Isabelle Funck-Brentano; Cécile Dalban; Florence Veber; Pierre Quartier; Serge Hefez; Dominique Costagliola; Stéphane Blanche
Evaluation of a peer support group therapy for HIV-infected adolescents.
AIDS (London, England) 2005;19(14):1501-8.
2005: Francis Barin; Laurence Meyer; Rémi Lancar; Christiane Deveau; Myriam Gharib; Anne Laporte; Jean-Claude Desenclos; Dominique Costagliola
Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.
Journal of clinical microbiology 2005;43(9):4441-7.
2005: Isabelle Heard; Valérie Potard; Hervé Foulot; Charles Chapron; Dominique Costagliola; Michel D Kazatchkine
High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women.
Journal of acquired immune deficiency syndromes (1999) 2005;39(4):412-8.
2005: Bernard Masquelier; Dominique Costagliola; Anne Schmuck; Jacqueline Cottalorda; Véronique Schneider; Jacques Izopet; Vincent Calvez; Diane Descamps; Cécile Poggi; Françoise Brun-Vézinet
Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
Journal of medical virology 2005;76(4):441-6.
2005: Roland Tubiana; Guislaine Carcelain; Muriel Vray; Karine Gourlain; Cécile Dalban; Aziza Chermak; Claire Rabian; Daniel Vittecoq; Anne Simon; Elisabeth Bouvet; Raphaelle El Habib; Dominique Costagliola; Vincent Calvez; Brigitte Autran; Christine Katlama
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).
Vaccine 2005;23(34):4292-301.
2005: Dorothea Stahl; Sébastien Lacroix-Desmazes; Namita Misra; Marina Karmochkine; Srini V Kaveri; Dominique Costagliola; Walter Sibrowski; Michel D Kazatchkine
Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells.
Immunology letters 2005;99(2):198-208.
2005: Sophie Grabar; Vincent Le Moing; Cécile Goujard; Matthias Egger; Catherine Leport; Michel D Kazatchkine; Laurence Weiss; Dominique Costagliola
Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):284-92.
2005: Karim Sacre; Guislaine Carcelain; Nathalie Cassoux; Anne-Marie Fillet; Dominique Costagliola; Daniel Vittecoq; Dominique Salmon; Zahir Amoura; Christine Katlama; Brigitte Autran
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
The Journal of experimental medicine 2005;201(12):1999-2010.
2005: Valérie Martinez; Dominique Costagliola; Olivia Bonduelle; Nicole N'go; Aurélie Schnuriger; Ioannis Théodorou; jean pierre clauvel; Didier Sicard; Henri Agut; Patrice Debré; Christine Rouzioux; Brigitte Autran
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.
The Journal of infectious diseases 2005;191(12):2053-63.
2005: Dominique Salmon-Ceron; Charlotte Lewden; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
Journal of hepatology 2005;42(6):799-805.
2005: Diane Descamps; Marie-Laure Chaix; Patrice André; Véronique Brodard; Jacqueline Cottalorda; Christiane Deveau; Martine Harzic; Didier Ingrand; Jacques Izopet; Evelyne Kohli; Bernard Masquelier; Said Mouajjah; Pierre Palmer; Isabelle Pellegrin; Jean-Christophe Plantier; Cécile Poggi; Sylvie Rogez; Annick Ruffault; Véronique Schneider; Anne Signori-Schmück; Catherine Tamalet; Marc Wirden; Christine Rouzioux; Françoise Brun Vezinet; Laurence Meyer; Dominique Costagliola
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Journal of acquired immune deficiency syndromes (1999) 2005;38(5):545-52.
2005: Charlotte Lewden; Dominique Salmon; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
International journal of epidemiology 2005;34(1):121-30.
2005: N Alatrakchi; Claudine Duvivier; Dominique Costagliola; Assia Samri; Anne-Geneviève Marcelin; G Kamkamidze; M Astriti; Rachid Agher; Vincent Calvez; Brigitte Autran; Christine Katlama
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
AIDS (London, England) 2005;19(1):25-33.
2005: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.
Scandinavian journal of infectious diseases 2005;37(6-7):482-7.
2005: Dominique Costagliola; Valérie Potard; Claudine Duvivier; Christian Pradier; Caroline Dupont; Dominique Salmon; Xavier Duval
Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals.
Antiviral therapy 2005;10(4):563-73.
2005: Jade Ghosn; Marguerite Guiguet; Claude Jardel; Rabah Benyaou; Valérie Zeller; Anne Simon; Marc-Antoine Valantin; Bahia Amellal; Lambert Assoumo; Jean-Yves Hogrel; Dominique Costagliola; Christine Katlama; Anne Lombès
Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study.
Antiviral therapy 2005;10(4):543-50.
2004: thierry may; Charlotte Lewden; F Bonnet; Laurence Heripret; Sibylle Bevilacqua; Eric Jougla; Dominique Costagliola; Philippe Morlat; Dominique Salmon; Geneviève Chêne
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment].
Presse médicale (Paris, France : 1983) 2004;33(21):1487-92.
2004: Anne-Geneviève Marcelin; Cécile Dalban; Gilles Peytavin; Claire Lamotte; Rachid Agher; Constance Delaugerre; Marc Wirden; Françoise Conan; Sylvie Dantin; Christine Katlama; Dominique Costagliola; Vincent Calvez
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2004;48(12):4687-92.
2004: Sophie Grabar; Isabelle Kousignian; Alain Sobel; Philippe Le Bras; Jacques Gasnault; Patricia Enel; Corinne Jung; Aba Mahamat; Jean-Marie Lang; Dominique Costagliola
Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV.
AIDS (London, England) 2004;18(15):2029-38.
2004: Philippe Bossi; Gilles Peytavin; Hocine Ait Mohand; Constance Delaugerre; Nadine Ktorza; Luc Paris; Manuela Bonmarchand; R Cacace; D-J David; Anne Simon; Claire Lamotte; Anne-Geneviève Marcelin; Vincent Calvez; François Bricaire; Dominique Costagliola; Christine Katlama
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
HIV medicine 2004;5(5):352-9.
2004: Anne-Geneviève Marcelin; Dissou Affolabi; Claire Lamotte; Hocine Ait Mohand; Constance Delaugerre; Marc Wirden; Delphine Voujon; Philippe Bossi; Nadine Ktorza; François Bricaire; Dominique Costagliola; Christine Katlama; Gilles Peytavin; Vincent Calvez
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients.
Journal of medical virology 2004;74(1):16-20.
2004: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Cancer 2004;101(2):317-24.
2004: Bernard Masquelier; Catherine Tamalet; Brigitte Montès; Diane Descamps; Gilles Peytavin; Laurence Bocket; Marc Wirden; Jacques Izopet; Véronique Schneider; Virginie Ferré; Annick Ruffault; Pierre Palmer; Aldo Trylesinski; M Miller; Françoise Brun-Vézinet; Dominique Costagliola
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients.
Antiviral therapy 2004;9(3):315-23.
2004: Isabelle Heard; Valérie Potard; Dominique Costagliola; Michel D Kazatchkine
Contraceptive use in HIV-positive women.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):714-20.
2004: Virginie Supervie; Dominique Costagliola
The unrecognised French BSE epidemic.
Veterinary research 2004;35(3):349-62.
2004: STEPHANE LASTERE; Cécile Dalban; Gilles Collin; Diane Descamps; Pierre-Marie Girard; François Clavel; Dominique Costagliola; Françoise Brun Vezinet
Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.
Antiviral therapy 2004;9(2):221-7.
2004: Marc Wirden; Constance Delaugerre; Anne-Geneviève Marcelin; Nadine Ktorza; Hocine Ait Mohand; Stephanie Dominguez; Luminita Schneider; Jade Ghosn; Michele Pauchard; Dominique Costagliola; Christine Katlama; Vincent Calvez
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.
Antimicrobial agents and chemotherapy 2004;48(2):644-7.
2004: Christine Katlama; Stephanie Dominguez; Karine Gourlain; Claudine Duvivier; Constance Delaugerre; Mayeule Legrand; Roland Tubiana; Jacques Reynes; Jean-Michel Molina; Gilles Peytavin; Vincent Calvez; Dominique Costagliola
Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097).
AIDS (London, England) 2004;18(2):217-26.
2003: Marie-Laure Chaix; Diane Descamps; Martine Harzic; Véronique Schneider; Christiane Deveau; Catherine Tamalet; Isabelle Pellegrin; Jacques Izopet; Annick Ruffault; Bernard Masquelier; Laurence Meyer; Christine Rouzioux; Françoise Brun Vezinet; Dominique Costagliola
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.
AIDS (London, England) 2003;17(18):2635-43.
2003: Claudine Duvivier; Astriti Myrto; Anne-Geneviève Marcelin; Jade Ghosn; Hocine Ait Mohand; Luminita Schneider; Rachid Agher; François Bricaire; Dominique Costagliola; Vincent Calvez; Gilles Peytavin; Christine Katlama
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Antiviral therapy 2003;8(6):603-9.
2003: Sophie Abgrall; Xavier Duval; Véronique Joly; Diane Descamps; Sophie Matheron; Dominique Costagliola
Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(11):1517-26.
2003: Murielle Mary-Krause; Laurent Cotte; Anne Simon; Maria Partisani; Dominique Costagliola
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
AIDS (London, England) 2003;17(17):2479-86.
2003: Muriel Vray; Jean-Luc Meynard; Cécile Dalban; Laurence Morand-Joubert; François Clavel; Françoise Brun-Vézinet; Gilles Peytavin; Dominique Costagliola; Pierre-Marie Girard
Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).
Antiviral therapy 2003;8(5):427-34.
2003: Magid Herida; Murielle Mary-Krause; Régis Kaphan; Jacques Cadranel; Isabelle Poizot-Martin; Christian Rabaud; Nathalie Plaisance; Hervé Tissot-Dupont; François Boue; Jean-Marie Lang; Dominique Costagliola
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3447-53.
2003: Isabelle Kousignian; Sophie Abgrall; Xavier Duval; Diane Descamps; Sophie Matheron; Dominique Costagliola
Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34(1):50-7.
2003: Françoise Brun-Vézinet; Diane Descamps; Annick Ruffault; Bernard Masquelier; Vincent Calvez; Gilles Peytavin; Fabienne Telles; Laurence Morand-Joubert; Jean-Luc Meynard; Muriel Vray; Dominique Costagliola
Clinically relevant interpretation of genotype for resistance to abacavir.
AIDS (London, England) 2003;17(12):1795-802.
2003: Constance Delaugerre; Karine Gourlain; Roland Tubiana; Guislaine Carcelain; Anne-Geneviève Marcelin; Cécile Chouquet; Mireille Mouroux; Claudine Duvivier; Brigitte Autran; Dominique Costagliola; Christine Katlama; Vincent Calvez
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Antiviral therapy 2003;8(3):233-7.
2003: I Kousignian; Brigitte Autran; Cécile Chouquet; Vincent Calvez; Elisabeth Gomard; Christine Katlama; Yves Rivière; Dominique Costagliola
Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
Statistics in medicine 2003;22(10):1675-90.
2003: Marie-Christine Mazeron; Anne-Marie Fillet; Dominique Salmon; Narjis Boukli; Nadhira Houhou; Brigitte Sénéchal; Sophie Matheron; joel gozlan; Catherine Leport; Christine Katlama; Catherine Scieux; Berthe-Marie Imbert; Paul Deny; Jean-Baptiste Bour; François Freymuth; Bruno Chanzy; Sophie Chaput; Dominique Costagliola
Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2003;17(5):784-6.
2003: Karine Gourlain; Dominique Salmon; Elyanne Gault; Catherine Leport; Christine Katlama; Sophie Matheron; Dominique Costagliola; Marie-Christine Mazeron; Anne-Marie Fillet
Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Journal of medical virology 2003;69(3):401-7.
2003: Anne-Geneviève Marcelin; Claire Lamotte; Constance Delaugerre; Nadine Ktorza; Hocine Ait Mohand; Raquel Cacace; Manuela Bonmarchand; Marc Wirden; Anne Simon; Philippe Bossi; François Bricaire; Dominique Costagliola; Christine Katlama; Gilles Peytavin; Vincent Calvez
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2003;47(2):594-600.
2002: Cécile Chouquet; Brigitte Autran; Elisabeth Gomard; Jean-Marc Bouley; Vincent Calvez; Christine Katlama; Dominique Costagliola; Yves Rivière
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.
AIDS (London, England) 2002;16(18):2399-407.
2002: Christine Katlama; Guislaine Carcelain; Claudine Duvivier; Cécile Chouquet; Roland Tubiana; Marcio De-Sa; Liliane Zagury; Vincent Calvez; Brigitte Autran; Dominique Costagliola
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
AIDS (London, England) 2002;16(15):2027-34.
2002: Vincent Calvez; Dominique Costagliola; Diane Descamps; Anne Yvon; Gilles Collin; Agnès Cécile; Constance Delaugerre; Florence Damond; Anne-Geneviève Marcelin; Sophie Matheron; Anne Simon; Marc-Antoine Valantin; Christine Katlama; Françoise Brun-Vézinet
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Antiviral therapy 2002;7(3):211-8.
2002: Jérôme N Huillard d'Aignaux; Simon Cousens; Jean Maccario; Dominique Costagliola; Michael P Alpers; Peter G Smith; Annick Alpérovitch
The incubation period of kuru.
Epidemiology (Cambridge, Mass.) 2002;13(4):402-8.
2002: Jean-Michel Tassie; Sophie Grabar; Rémi Lancar; Jacqueline Deloumeaux; Michelle Bentata; Dominique Costagliola
Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection.
Journal of acquired immune deficiency syndromes (1999) 2002;30(1):81-7.
2002: Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Ester Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.
AIDS (London, England) 2002;16(5):727-36.
2001: C Besson; A Goubar; Jean Gabarre; Willy Rozenbaum; Gilles Pialoux; François Châtelet; C Katlama; Frédéric Charlotte; B Dupont; N Brousse; M Huerre; J Mikol; Philippe Camparo; Karima Mokhtari; M Tulliez; Dominique Salmon-Céron; François Boué; Dominique Costagliola; Martine Raphaël
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.
Blood 2001;98(8):2339-44.
2001: N Ngo-Giang-Huong; D Candotti; A Goubar; Brigitte Autran; M Maynart; Didier Sicard; jean pierre clauvel; Henri Agut; Dominique Costagliola; Christine Rouzioux
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
AIDS research and human retroviruses 2001;17(15):1435-46.
2001: Diane Descamps; Vincent Calvez; Jacques Izopet; Claudine Buffet-Janvresse; Anne Schmuck; Philippe Colson; Annick Ruffault; A Maillard; Bernard Masquelier; Jacqueline Cottalorda; Martine Harzic; Françoise Brun-Vézinet; Dominique Costagliola
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001;15(14):1777-82.
2001: Mireille Mouroux; Diane Descamps; Jacques Izopet; Anne Yvon; Constance Delaugerre; Sophie Matheron; A Coutellier; Marc-Antoine Valantin; Manuela Bonmarchand; Henri Agut; P Massip; Dominique Costagliola; Christine Katlama; Françoise Brun Vezinet; Vincent Calvez
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Antiviral therapy 2001;6(3):179-83.
2001: A Goubar; Dominique Costagliola
HIV incidence estimates among women of childbearing age in the area around Paris, France: no evidence for any effect of age or time.
Journal of acquired immune deficiency syndromes (1999) 2001;27(5):492-8.
2001: Sophie Abgrall; Sophie Matheron; V Le Moing; C Dupont; Dominique Costagliola
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
Journal of acquired immune deficiency syndromes (1999) 2001;26(2):151-8.
2000: Dominique Salmon-Céron; Marie-Christine Mazeron; Sophie Chaput; Narjis Boukli; B Senechal; Nadhira Houhou; Christine Katlama; Sophie Matheron; Anne-Marie Fillet; joel gozlan; Catherine Leport; V Jeantils; François Freymuth; Dominique Costagliola
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2000;14(8):1041-9.
2000: B M Anduze-Faris; Anne-Marie Fillet; joel gozlan; R Lancar; Narjis Boukli; Jacques Gasnault; E Caumes; J Livartowsky; Sophie Matheron; Catherine Leport; Dominique Salmon; Dominique Costagliola; Christine Katlama
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients.
AIDS (London, England) 2000;14(5):517-24.
2000: Sophie Faure; L Meyer; Dominique Costagliola; C Vaneensberghe; E Genin; Brigitte Autran; J F Delfraissy; D H McDermott; Philip M Murphy; Patrice Debré; Ioannis Théodorou; Christophe Combadière
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.
Science (New York, N.Y.) 2000;287(5461):2274-7.
2000: Sophie Grabar; C Pradier; E Le Corfec; Rémi Lancar; Clotilde Allavena; Michelle Bentata; P Berlureau; C Dupont; P Fabbro-Peray; Isabelle Poizot-Martin; Dominique Costagliola
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.
AIDS (London, England) 2000;14(2):141-9.
1999: Andrew N Phillips; Sophie Grabar; Jean-Michel Tassie; Dominique Costagliola; Jens D Lundgren; Matthias Egger
Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.
AIDS (London, England) 1999;13(15):2075-82.
1999: Jérôme N Huillard d'Aignaux; Dominique Costagliola; Jean Maccario; T Billette de Villemeur; Jean-Philippe Brandel; Jean-Philippe Deslys; JEAN-JACQUES HAUW; J L Chaussain; Yves Agid; D Dormont; Annick Alpérovitch
Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.
Neurology 1999;53(6):1197-201.
1999: Jean-Michel Tassie; Jacques Gasnault; Michelle Bentata; Jacqueline Deloumeaux; François Boué; Eric Billaud; Dominique Costagliola
Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.
AIDS (London, England) 1999;13(14):1881-7.
1999: D Candotti; Dominique Costagliola; C Joberty; Olivia Bonduelle; Christine Rouzioux; Brigitte Autran; Henri Agut
Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
Journal of medical virology 1999;58(3):256-63.
1999: M Magierowska; Ioannis Theodorou; Patrice Debré; F Sanson; Brigitte Autran; Y Rivière; Dominique Charron; Dominique Costagliola
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.
Blood 1999;93(3):936-41.
1998: Christine Katlama; Marc-Antoine Valantin; Sophie Matheron; A Coutellier; Vincent Calvez; Diane Descamps; C Longuet; Manuela Bonmarchand; Roland Tubiana; Marcio De-Sa; R Lancar; Henri Agut; Françoise Brun Vezinet; Dominique Costagliola
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
Annals of internal medicine 1998;129(7):525-31.
1998: Isabelle Heard; V Schmitz; Dominique Costagliola; Gérard Orth; Michel D Kazatchkine
Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
AIDS (London, England) 1998;12(12):1459-64.
1998: M Uchuya; A Fleury; Francesc Graus; Dominique Costagliola; Roland S Liblau; Hélène Merle-Beral; I Théodorou; Jean-Yves Delattre
Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer.
Neurology 1998;50(2):565-6.
1997: Isabelle Funck-Brentano; Dominique Costagliola; N Seibel; E Straub; M Tardieu; Stéphane Blanche
Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children.
Archives of pediatrics & adolescent medicine 1997;151(10):978-85.